Novo Nordisk CEO steps down amid market challenges, including competition from Eli Lilly's rival drug and setbacks with Novo Nordisk's obesity treatments.
Russian cyberattacks disrupt Polish ruling party's websites ahead of election, raising concerns about foreign interference in democratic processes.
Suns face fourth lawsuit over security and discrimination allegations, denying all claims as 'delusional and categorically false'.
Novo Nordisk CEO steps down amid market challenges, including competition from Eli Lilly's rival drug and setbacks with Novo Nordisk's obesity treatments.
Russian cyberattacks disrupt Polish ruling party's websites ahead of election, raising concerns about foreign interference in democratic processes.
Suns face fourth lawsuit over security and discrimination allegations, denying all claims as 'delusional and categorically false'.